A recent study suggests that patients who stop using popular slimming jabs like semaglutide or tirzepatide can put back on shed pounds far faster than those who halt traditional diet and exercise regimens.
Published data in a prominent health publication points out that while overweight individuals can lose a large proportion of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Individuals buying these drugs should be cognizant of the potential of fast weight regain when the therapy ends," stated expert Dr. Susan Jebb.
That rate of regain implies a reversion to pre-treatment mass within about a year and a half.
Analyzing Therapies
The study, which looked at 37 of studies involving over 9,000 of patients, compared the results of the injectable medications with conventional dieting.
Scientists emphasize that individuals who shed pounds through diet and exercise generally see a more gradual weight regain—approximately 0.1 kg a month—once they finish.
The Reason for the Quick Regain
Doctors believe the way of the drugs is key to understanding the amplified weight return.
These medications mimic a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Artificially providing the hormone concentrations several times higher than normal may cause the body to produce less of its own natural GLP-1, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this medication leads to hunger is uncontrolled, making overeating much more probable."
A Chronic Issue?
The NHS suggest the injections for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Professionals argue that, due to the significant potential of relapse, the therapy should be considered ongoing.
This opinion is reinforced by drug manufacturers, who state that the findings "underscore the persistent nature of excess weight," akin to managing diseases like hypertension.
Patient Accounts
Individuals who have come off the medication describe a intense return of cravings.
"It felt as if a switch that goes on and you become ravenous," described one woman.
This challenge is compounded if individuals have not established sustainable lifestyle or habit changes during therapy.
Widespread Use
Recent estimates suggest that millions of people in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
Ultimately, experts caution that while these medications are powerful agents for shedding pounds, they are not a standalone cure and maintained weight loss hinges on combined lifestyle management.